Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy
- PMID: 11356793
- DOI: 10.1152/jappl.2001.90.6.2279
Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy
Abstract
Microvascular degeneration is an important event in oxygen-induced retinopathy (OIR), a model of retinopathy of prematurity. Because oxidant stress abundantly generates thromboxane A2 (TxA2), we tested whether TxA2 plays a role in retinal vasoobliteration of OIR and contributes to such vascular degeneration by direct endothelial cytotoxicity. Hyperoxia-induced retinal vasoobliteration in rat pups (80% O2 exposure from postnatal days 5-14) was associated with increased TxB2 generation and was significantly prevented by TxA2 synthase inhibitor CGS-12970 (10 mg x kg(-1) x day(-1)) or TxA2-receptor antagonist CGS-22652 (10 mg x kg(-1) x day(-1)). TxA2 mimetics U-46619 (EC50 50 nM) and I-BOP (EC50 5 nM) caused a time- and concentration-dependent cell death of neuroretinovascular endothelial cells from rats as well as newborn pigs but not of smooth muscle and astroglial cells; other prostanoids did not cause cell death. The peroxidation product 8-iso-PGF2, which is generated in OIR, stimulated TxA2 formation by endothelial cells and triggered cell death; these effects were markedly diminished by CGS-12970. TxA2-dependent neuroretinovascular endothelial cell death was mostly by necrosis and to a lesser extent by apoptosis. The data identify an important role for TxA2 in vasoobliteration of OIR and unveil a so far unknown function for TxA2 in directly triggering neuroretinal microvascular endothelial cell death. These effects of TxA2 might participate in other ischemic neurovascular injuries.
Similar articles
-
Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3327-37. Invest Ophthalmol Vis Sci. 2002. PMID: 12356842
-
Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury.Stroke. 2003 Mar;34(3):776-82. doi: 10.1161/01.STR.0000055763.76479.E6. Epub 2003 Feb 20. Stroke. 2003. PMID: 12624307
-
New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy.Prostaglandins Leukot Essent Fatty Acids. 2005 May;72(5):301-25. doi: 10.1016/j.plefa.2005.02.004. Prostaglandins Leukot Essent Fatty Acids. 2005. PMID: 15850712 Review.
-
Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy.Free Radic Biol Med. 2004 Dec 1;37(11):1885-94. doi: 10.1016/j.freeradbiomed.2004.09.008. Free Radic Biol Med. 2004. PMID: 15528047
-
Inflammatory lipid mediators in ischemic retinopathy.Pharmacol Rep. 2005;57 Suppl:169-90. Pharmacol Rep. 2005. PMID: 16415498 Review.
Cited by
-
Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.J Clin Invest. 2010 Sep;120(9):3022-32. doi: 10.1172/JCI42142. Epub 2010 Sep 1. J Clin Invest. 2010. PMID: 20811158 Free PMC article. Review.
-
The Role and Regulation of Thromboxane A2 Signaling in Cancer-Trojan Horses and Misdirection.Molecules. 2022 Sep 22;27(19):6234. doi: 10.3390/molecules27196234. Molecules. 2022. PMID: 36234768 Free PMC article. Review.
-
Antenatal and Postnatal Sequelae of Oxidative Stress in Preterm Infants: A Narrative Review Targeting Pathophysiological Mechanisms.Antioxidants (Basel). 2023 Feb 9;12(2):422. doi: 10.3390/antiox12020422. Antioxidants (Basel). 2023. PMID: 36829980 Free PMC article. Review.
-
Retinopathy of prematurity: Metabolic risk factors.Elife. 2022 Nov 24;11:e80550. doi: 10.7554/eLife.80550. Elife. 2022. PMID: 36420952 Free PMC article.
-
Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia.Biomark Insights. 2008 May 27;3:419-428. doi: 10.4137/bmi.s363. Biomark Insights. 2008. PMID: 19578522 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical